{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:10:28Z","timestamp":1791169828257,"version":"4.1.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,13]],"date-time":"2013-01-13T00:00:00Z","timestamp":1358035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12035-013-8399-5","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T06:04:28Z","timestamp":1357970668000},"page":"821-832","source":"Crossref","is-referenced-by-count":30,"title":["Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein"],"prefix":"10.1007","volume":"47","author":[{"given":"Ryan S.","family":"Anderton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Boulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,13]]},"reference":[{"issue":"5\u20136","key":"8399_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE (1992) International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany). Neuromuscul Disord 2(5\u20136):423\u2013428","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"8399_CR2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nmd.2005.07.005","volume":"15","author":"E Bertini","year":"2005","unstructured":"Bertini E et al (2005) 134th ENMC International workshop: outcome measures and treatment of spinal muscular atrophy, 11\u201313 february, 2005 Naarden, The Netherlands. Neuromuscul Disord 15(11):802\u2013816","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"8399_CR3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.47.4.973","volume":"47","author":"BS Russman","year":"1996","unstructured":"Russman BS et al (1996) Function changes in spinal muscular atrophy II and III. The DCN\/SMA Group. Neurology 47(4):973\u2013976","journal-title":"Neurology"},{"issue":"3","key":"8399_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15(3):228\u2013237","journal-title":"Hum Mutat"},{"issue":"6658","key":"8399_CR5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/37144","volume":"390","author":"H Iwahashi","year":"1997","unstructured":"Iwahashi H et al (1997) Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390(6658):413\u2013417","journal-title":"Nature"},{"issue":"4","key":"8399_CR6","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1074\/jbc.M108769200","volume":"277","author":"PJ Young","year":"2002","unstructured":"Young PJ et al (2002) A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J Biol Chem 277(4):2852\u20132859","journal-title":"J Biol Chem"},{"issue":"4","key":"8399_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/35070059","volume":"3","author":"L Gangwani","year":"2001","unstructured":"Gangwani L et al (2001) Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Nat Cell Biol 3(4):376\u2013383","journal-title":"Nat Cell Biol"},{"issue":"4","key":"8399_CR8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnen\/62.4.420","volume":"62","author":"C Soler-Botija","year":"2003","unstructured":"Soler-Botija C et al (2003) Downregulation of Bcl-2 proteins in type I spinal muscular atrophy motor neurons during fetal development. J Neuropathol Exp Neurol 62(4):420\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"8399_CR9","doi-asserted-by":"crossref","unstructured":"Anderton RS et al (2012) Co-regulation of survival of motor neuron and Bcl-xL expression: Implications for neuroprotection in spinal muscular atrophy. Neuroscience 220:228\u2013236","DOI":"10.1016\/j.neuroscience.2012.06.042"},{"issue":"1","key":"8399_CR10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155\u2013165","journal-title":"Cell"},{"issue":"3","key":"8399_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","volume":"108","author":"CF Rochette","year":"2001","unstructured":"Rochette CF, Gilbert N, Simard LR (2001) SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum Genet 108(3):255\u2013266","journal-title":"Hum Genet"},{"issue":"9","key":"8399_CR12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.ejhg.5201217","volume":"12","author":"B Boda","year":"2004","unstructured":"Boda B et al (2004) Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Eur J Hum Genet 12(9):729\u2013737","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"8399_CR13","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL et al (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96(11):6307\u20136311","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"8399_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR (2002) Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30(4):377\u2013384","journal-title":"Nat Genet"},{"issue":"4","key":"8399_CR15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima T, Manley JL (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34(4):460\u2013463","journal-title":"Nat Genet"},{"issue":"48","key":"8399_CR16","doi-asserted-by":"crossref","first-page":"45387","DOI":"10.1074\/jbc.M105059200","volume":"276","author":"J Wang","year":"2001","unstructured":"Wang J, Dreyfuss G (2001) Characterization of functional domains of the SMN protein in vivo. J Biol Chem 276(48):45387\u201345393","journal-title":"J Biol Chem"},{"issue":"5","key":"8399_CR17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","volume":"9","author":"T Frugier","year":"2000","unstructured":"Frugier T et al (2000) Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 9(5):849\u2013858","journal-title":"Hum Mol Genet"},{"issue":"20","key":"8399_CR18","doi-asserted-by":"crossref","first-page":"11167","DOI":"10.1073\/pnas.96.20.11167","volume":"96","author":"L Pellizzoni","year":"1999","unstructured":"Pellizzoni L, Charroux B, Dreyfuss G (1999) SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci USA 96(20):11167\u201311172","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"8399_CR19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett BG et al (2009) Regulation of SMN protein stability. Mol Cell Biol 29(5):1107\u20131115","journal-title":"Mol Cell Biol"},{"issue":"9","key":"8399_CR20","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/j.1460-9568.1998.00298.x","volume":"10","author":"V Bella La","year":"1998","unstructured":"La Bella V et al (1998) Survival motor neuron (SMN) protein in rat is expressed as different molecular forms and is developmentally regulated. Eur J Neurosci 10(9):2913\u20132923","journal-title":"Eur J Neurosci"},{"issue":"14","key":"8399_CR21","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15(14):3555\u20133565","journal-title":"EMBO J"},{"issue":"4","key":"8399_CR22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1083\/jcb.147.4.715","volume":"147","author":"T Carvalho","year":"1999","unstructured":"Carvalho T et al (1999) The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body. J Cell Biol 147(4):715\u2013728","journal-title":"J Cell Biol"},{"issue":"2","key":"8399_CR23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/excr.2001.5186","volume":"265","author":"PJ Young","year":"2001","unstructured":"Young PJ et al (2001) Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Exp Cell Res 265(2):252\u2013261","journal-title":"Exp Cell Res"},{"issue":"20","key":"8399_CR24","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1101\/gad.908401","volume":"15","author":"MD Hebert","year":"2001","unstructured":"Hebert MD et al (2001) Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev 15(20):2720\u20132729","journal-title":"Genes Dev"},{"issue":"1","key":"8399_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2004.03.022","volume":"296","author":"AK Gubitz","year":"2004","unstructured":"Gubitz AK, Feng W, Dreyfuss G (2004) The SMN complex. Exp Cell Res 296(1):51\u201356","journal-title":"Exp Cell Res"},{"issue":"11","key":"8399_CR26","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1073\/pnas.95.11.6492","volume":"95","author":"JW Francis","year":"1998","unstructured":"Francis JW et al (1998) Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues. Proc Natl Acad Sci USA 95(11):6492\u20136497","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8399_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/hmg\/9.1.47","volume":"9","author":"S Pagliardini","year":"2000","unstructured":"Pagliardini S et al (2000) Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum Mol Genet 9(1):47\u201356","journal-title":"Hum Mol Genet"},{"issue":"8","key":"8399_CR28","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/00001756-199906030-00003","volume":"10","author":"A Broccolini","year":"1999","unstructured":"Broccolini A, Engel WK, Askanas V (1999) Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibers, and neuromuscular junctions. Neuroreport 10(8):1637\u20131641","journal-title":"Neuroreport"},{"issue":"11","key":"8399_CR29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/hmg\/6.11.1961","volume":"6","author":"G Battaglia","year":"1997","unstructured":"Battaglia G et al (1997) Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet 6(11):1961\u20131971","journal-title":"Hum Mol Genet"},{"issue":"1","key":"8399_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/MCB.06077-11","volume":"32","author":"M Ruggiu","year":"2012","unstructured":"Ruggiu M et al (2012) A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy. Mol Cell Biol 32(1):126\u2013138","journal-title":"Mol Cell Biol"},{"issue":"3","key":"8399_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-008-0411-1","volume":"116","author":"G Simic","year":"2008","unstructured":"Simic G (2008) Pathogenesis of proximal autosomal recessive spinal muscular atrophy. Acta Neuropathol 116(3):223\u2013234","journal-title":"Acta Neuropathol"},{"issue":"6","key":"8399_CR32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0092-8674(00)80367-0","volume":"90","author":"Q Liu","year":"1997","unstructured":"Liu Q et al (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90(6):1013\u20131021","journal-title":"Cell"},{"issue":"6","key":"8399_CR33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1083\/jcb.147.6.1181","volume":"147","author":"B Charroux","year":"1999","unstructured":"Charroux B et al (1999) Gemin3: a novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol 147(6):1181\u20131194","journal-title":"J Cell Biol"},{"issue":"6","key":"8399_CR34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.148.6.1177","volume":"148","author":"B Charroux","year":"2000","unstructured":"Charroux B et al (2000) Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli. J Cell Biol 148(6):1177\u20131186","journal-title":"J Cell Biol"},{"issue":"35","key":"8399_CR35","doi-asserted-by":"crossref","first-page":"31957","DOI":"10.1074\/jbc.M203478200","volume":"277","author":"J Baccon","year":"2002","unstructured":"Baccon J et al (2002) Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex. J Biol Chem 277(35):31957\u201331962","journal-title":"J Biol Chem"},{"issue":"7","key":"8399_CR36","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1074\/jbc.M109448200","volume":"277","author":"AK Gubitz","year":"2002","unstructured":"Gubitz AK et al (2002) Gemin5, a novel WD repeat protein component of the SMN complex that binds Sm proteins. J Biol Chem 277(7):5631\u20135636","journal-title":"J Biol Chem"},{"issue":"5599","key":"8399_CR37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","volume":"298","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni L, Yong J, Dreyfuss G (2002) Essential role for the SMN complex in the specificity of snRNP assembly. Science 298(5599):1775\u20131779","journal-title":"Science"},{"issue":"12","key":"8399_CR38","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1074\/jbc.M512243200","volume":"281","author":"C Carissimi","year":"2006","unstructured":"Carissimi C et al (2006) Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly. J Biol Chem 281(12):8126\u20138134","journal-title":"J Biol Chem"},{"issue":"10","key":"8399_CR39","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/MCB.19.10.6554","volume":"19","author":"VA Raker","year":"1999","unstructured":"Raker VA et al (1999) Spliceosomal U snRNP core assembly: Sm proteins assemble onto an Sm site RNA nonanucleotide in a specific and thermodynamically stable manner. Mol Cell Biol 19(10):6554\u20136565","journal-title":"Mol Cell Biol"},{"issue":"4","key":"8399_CR40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.embor.7400941","volume":"8","author":"L Pellizzoni","year":"2007","unstructured":"Pellizzoni L (2007) Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep 8(4):340\u2013345","journal-title":"EMBO Rep"},{"issue":"8","key":"8399_CR41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/0883073807305666","volume":"22","author":"SJ Kolb","year":"2007","unstructured":"Kolb SJ, Battle DJ, Dreyfuss G (2007) Molecular functions of the SMN complex. J Child Neurol 22(8):990\u2013994","journal-title":"J Child Neurol"},{"issue":"3","key":"8399_CR42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0955-0674(00)00211-8","volume":"13","author":"CL Will","year":"2001","unstructured":"Will CL, Luhrmann R (2001) Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 13(3):290\u2013301","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"8399_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21428","volume":"41","author":"SJ Kolb","year":"2010","unstructured":"Kolb SJ, Sutton S, Schoenberg DR (2010) RNA processing defects associated with diseases of the motor neuron. Muscle Nerve 41(1):5\u201317","journal-title":"Muscle Nerve"},{"issue":"8","key":"8399_CR44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 10(8):597\u2013609","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"8399_CR45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","volume":"151","author":"F Lotti","year":"2012","unstructured":"Lotti F et al (2012) An SMN-dependent U12 splicing event essential for motor circuit function. Cell 151(2):440\u2013454","journal-title":"Cell"},{"issue":"16","key":"8399_CR46","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.23-16-06627.2003","volume":"23","author":"HL Zhang","year":"2003","unstructured":"Zhang HL et al (2003) Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 23(16):6627\u20136637","journal-title":"J Neurosci"},{"issue":"5","key":"8399_CR47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","volume":"162","author":"ML McWhorter","year":"2003","unstructured":"McWhorter ML et al (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 162(5):919\u2013931","journal-title":"J Cell Biol"},{"issue":"43","key":"8399_CR48","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1523\/JNEUROSCI.1637-06.2006","volume":"26","author":"TL Carrel","year":"2006","unstructured":"Carrel TL et al (2006) Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J Neurosci 26(43):11014\u201311022","journal-title":"J Neurosci"},{"issue":"10","key":"8399_CR49","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1523\/JNEUROSCI.3631-10.2011","volume":"31","author":"C Fallini","year":"2011","unstructured":"Fallini C et al (2011) The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons. J Neurosci 31(10):3914\u20133925","journal-title":"J Neurosci"},{"issue":"4","key":"8399_CR50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239\u2013257","journal-title":"Br J Cancer"},{"issue":"4","key":"8399_CR51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516","journal-title":"Toxicol Pathol"},{"issue":"2","key":"8399_CR52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","volume":"1","author":"MP Mattson","year":"2000","unstructured":"Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1(2):120\u2013129","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"8399_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1073858404269267","volume":"11","author":"T Lindsten","year":"2005","unstructured":"Lindsten T, Zong WX, Thompson CB (2005) Defining the role of the Bcl-2 family of proteins in the nervous system. Neuroscientist 11(1):10\u201315","journal-title":"Neuroscientist"},{"key":"8399_CR54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ne.14.030191.002321","volume":"14","author":"RW Oppenheim","year":"1991","unstructured":"Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453\u2013501","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"8399_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1020605112755","volume":"13","author":"P Desjardins","year":"1998","unstructured":"Desjardins P, Ledoux S (1998) The role of apoptosis in neurodegenerative diseases. Metab Brain Dis 13(2):79\u201396","journal-title":"Metab Brain Dis"},{"issue":"5","key":"8399_CR56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-199905000-00005","volume":"58","author":"LJ Martin","year":"1999","unstructured":"Martin LJ (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 58(5):459\u2013471","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"8399_CR57","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","volume":"2","author":"DW Cleveland","year":"2001","unstructured":"Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2(11):806\u2013819","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"8399_CR58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jnen\/59.5.398","volume":"59","author":"G Simic","year":"2000","unstructured":"Simic G et al (2000) Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig\u2013Hoffmann disease. J Neuropathol Exp Neurol 59(5):398\u2013407","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 7","key":"8399_CR59","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/brain\/awf155","volume":"125","author":"C Soler-Botija","year":"2002","unstructured":"Soler-Botija C et al (2002) Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord. Brain 125(Pt 7):1624\u20131634","journal-title":"Brain"},{"issue":"6","key":"8399_CR60","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ymthe.2006.02.008","volume":"13","author":"MS Tsai","year":"2006","unstructured":"Tsai MS et al (2006) Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice. Mol Ther 13(6):1149\u20131155","journal-title":"Mol Ther"},{"issue":"3","key":"8399_CR61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.ejhg.5201556","volume":"14","author":"MS Tsai","year":"2006","unstructured":"Tsai MS et al (2006) Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice. Eur J Hum Genet 14(3):372\u2013375","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"8399_CR62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03033366","volume":"13","author":"GC Parker","year":"2008","unstructured":"Parker GC et al (2008) Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. Neurotox Res 13(1):39\u201348","journal-title":"Neurotox Res"},{"issue":"22","key":"8399_CR63","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1093\/hmg\/11.22.2751","volume":"11","author":"S Vyas","year":"2002","unstructured":"Vyas S et al (2002) Involvement of survival motor neuron (SMN) protein in cell death. Hum Mol Genet 11(22):2751\u20132764","journal-title":"Hum Mol Genet"},{"issue":"1","key":"8399_CR64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymgme.2004.12.015","volume":"85","author":"W Wang","year":"2005","unstructured":"Wang W et al (2005) Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death. Mol Genet Metab 85(1):38\u201345","journal-title":"Mol Genet Metab"},{"key":"8399_CR65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroscience.2011.02.032","volume":"181","author":"RS Anderton","year":"2011","unstructured":"Anderton RS et al (2011) Survival of motor neuron protein over-expression prevents calpain-mediated cleavage and activation of procaspase-3 in differentiated human SH-SY5Y cells. Neuroscience 181:226\u2013233","journal-title":"Neuroscience"},{"issue":"24","key":"8399_CR66","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.230364197","volume":"97","author":"DA Kerr","year":"2000","unstructured":"Kerr DA et al (2000) Survival motor neuron protein modulates neuron-specific apoptosis. Proc Natl Acad Sci USA 97(24):13312\u201313317","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"8399_CR67","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1074\/jbc.272.20.13432","volume":"272","author":"Z Han","year":"1997","unstructured":"Han Z et al (1997) A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem 272(20):13432\u201313436","journal-title":"J Biol Chem"},{"issue":"8","key":"8399_CR68","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/emboj\/17.8.2215","volume":"17","author":"QL Deveraux","year":"1998","unstructured":"Deveraux QL et al (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17(8):2215\u20132223","journal-title":"EMBO J"},{"issue":"Pt 1","key":"8399_CR69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/0264-6021:3490135","volume":"349","author":"T Meergans","year":"2000","unstructured":"Meergans T et al (2000) The short prodomain influences caspase-3 activation in HeLa cells. Biochem J 349(Pt 1):135\u2013140","journal-title":"Biochem J"},{"key":"8399_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.09.025","volume":"1183","author":"B Trulzsch","year":"2007","unstructured":"Trulzsch B et al (2007) Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells. Brain Res 1183:1\u20139","journal-title":"Brain Res"},{"issue":"6","key":"8399_CR71","doi-asserted-by":"crossref","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","volume":"7","author":"D Sareen","year":"2012","unstructured":"Sareen D et al (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One 7(6):e39113","journal-title":"PLoS One"},{"issue":"21","key":"8399_CR72","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/hmg\/ddn234","volume":"17","author":"MP Walker","year":"2008","unstructured":"Walker MP et al (2008) SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum Mol Genet 17(21):3399\u20133410","journal-title":"Hum Mol Genet"},{"issue":"12","key":"8399_CR73","doi-asserted-by":"crossref","first-page":"e15769","DOI":"10.1371\/journal.pone.0015769","volume":"5","author":"JL Fuentes","year":"2010","unstructured":"Fuentes JL, Strayer MS, Matera AG (2010) Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain. PLoS One 5(12):e15769","journal-title":"PLoS One"},{"issue":"15","key":"8399_CR74","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","volume":"13","author":"A Gross","year":"1999","unstructured":"Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13(15):1899\u20131911","journal-title":"Genes Dev"},{"issue":"3","key":"8399_CR75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1582-4934.2003.tb00225.x","volume":"7","author":"A Burlacu","year":"2003","unstructured":"Burlacu A (2003) Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7(3):249\u2013257","journal-title":"J Cell Mol Med"},{"issue":"4","key":"8399_CR76","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.cdd.4400660","volume":"7","author":"K Sato","year":"2000","unstructured":"Sato K et al (2000) Regions essential for the interaction between Bcl-2 and SMN, the spinal muscular atrophy disease gene product. Cell Death Differ 7(4):374\u2013383","journal-title":"Cell Death Differ"},{"issue":"Pt 9","key":"8399_CR77","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/brain\/awg208","volume":"126","author":"K Anderson","year":"2003","unstructured":"Anderson K et al (2003) Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain 126(Pt 9):2052\u20132064","journal-title":"Brain"},{"issue":"17","key":"8399_CR78","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1101\/gad.9.17.2143","volume":"9","author":"S Maheswaran","year":"1995","unstructured":"Maheswaran S et al (1995) The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 9(17):2143\u20132156","journal-title":"Genes Dev"},{"issue":"14","key":"8399_CR79","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/emboj\/18.14.3990","volume":"18","author":"MW Mayo","year":"1999","unstructured":"Mayo MW et al (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 18(14):3990\u20134003","journal-title":"EMBO J"},{"issue":"1","key":"8399_CR80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","volume":"114","author":"C Helmken","year":"2003","unstructured":"Helmken C et al (2003) Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 114(1):11\u201321","journal-title":"Hum Genet"},{"issue":"7","key":"8399_CR81","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1128\/MCB.25.7.2744-2756.2005","volume":"25","author":"L Gangwani","year":"2005","unstructured":"Gangwani L, Flavell RA, Davis RJ (2005) ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies. Mol Cell Biol 25(7):2744\u20132756","journal-title":"Mol Cell Biol"},{"issue":"19","key":"8399_CR82","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1073\/pnas.0602057103","volume":"103","author":"B Doran","year":"2006","unstructured":"Doran B et al (2006) Deficiency of the zinc finger protein ZPR1 causes neurodegeneration. Proc Natl Acad Sci USA 103(19):7471\u20137475","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"8399_CR83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0955-0674(00)00216-7","volume":"13","author":"KM Ryan","year":"2001","unstructured":"Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13(3):332\u2013337","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"8399_CR84","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/carcin\/23.4.541","volume":"23","author":"D Alarcon-Vargas","year":"2002","unstructured":"Alarcon-Vargas D, Ronai Z (2002) p53-Mdm2\u2014the affair that never ends. Carcinogenesis 23(4):541\u2013547","journal-title":"Carcinogenesis"},{"issue":"13","key":"8399_CR85","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.onc.1203468","volume":"19","author":"S Rozieres de","year":"2000","unstructured":"de Rozieres S et al (2000) The loss of mdm2 induces p53-mediated apoptosis. Oncogene 19(13):1691\u20131697","journal-title":"Oncogene"},{"issue":"4","key":"8399_CR86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","volume":"74","author":"LH Boise","year":"1993","unstructured":"Boise LH et al (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74(4):597\u2013608","journal-title":"Cell"},{"issue":"10","key":"8399_CR87","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1242\/dev.120.10.3033","volume":"120","author":"M Gonzalez-Garcia","year":"1994","unstructured":"Gonzalez-Garcia M et al (1994) bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120(10):3033\u20133042","journal-title":"Development"},{"issue":"15","key":"8399_CR88","first-page":"3115","volume":"57","author":"CN Kim","year":"1997","unstructured":"Kim CN et al (1997) Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 57(15):3115\u20133120","journal-title":"Cancer Res"},{"issue":"8","key":"8399_CR89","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.95.8.4386","volume":"95","author":"Y Hu","year":"1998","unstructured":"Hu Y et al (1998) Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95(8):4386\u20134391","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5203","key":"8399_CR90","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7878471","volume":"267","author":"N Motoyama","year":"1995","unstructured":"Motoyama N et al (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267(5203):1506\u20131510","journal-title":"Science"},{"issue":"3","key":"8399_CR91","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nbd.2008.05.014","volume":"31","author":"LK Tsai","year":"2008","unstructured":"Tsai LK et al (2008) Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy. Neurobiol Dis 31(3):361\u2013367","journal-title":"Neurobiol Dis"},{"issue":"7","key":"8399_CR92","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1083\/jcb.200701005","volume":"176","author":"MP Paronetto","year":"2007","unstructured":"Paronetto MP et al (2007) The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol 176(7):929\u2013939","journal-title":"J Cell Biol"},{"issue":"7","key":"8399_CR93","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/emboj.2010.19","volume":"29","author":"S Pedrotti","year":"2010","unstructured":"Pedrotti S et al (2010) The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy. EMBO J 29(7):1235\u20131247","journal-title":"EMBO J"},{"issue":"1","key":"8399_CR94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","volume":"80","author":"N Roy","year":"1995","unstructured":"Roy N et al (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80(1):167\u2013178","journal-title":"Cell"},{"issue":"5","key":"8399_CR95","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s004390050253","volume":"98","author":"E Samilchuk","year":"1996","unstructured":"Samilchuk E et al (1996) Deletion analysis of the SMN and NAIP genes in Kuwaiti patients with spinal muscular atrophy. Hum Genet 98(5):524\u2013527","journal-title":"Hum Genet"},{"issue":"3","key":"8399_CR96","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<378::AID-MUS17>3.0.CO;2-O","volume":"19","author":"F Capon","year":"1996","unstructured":"Capon F et al (1996) Deletion analysis of SMN and NAIP genes in spinal muscular atrophy Italian families. Muscle Nerve 19(3):378\u2013380","journal-title":"Muscle Nerve"},{"issue":"5\u20136","key":"8399_CR97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004390050555","volume":"100","author":"JG Chang","year":"1997","unstructured":"Chang JG et al (1997) Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents. Hum Genet 100(5\u20136):577\u2013581","journal-title":"Hum Genet"},{"issue":"1\u20132","key":"8399_CR98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(01)00574-3","volume":"190","author":"CH Tsai","year":"2001","unstructured":"Tsai CH et al (2001) Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families. J Neurol Sci 190(1\u20132):35\u201340","journal-title":"J Neurol Sci"},{"issue":"6","key":"8399_CR99","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00415-005-0714-2","volume":"252","author":"A Kesari","year":"2005","unstructured":"Kesari A et al (2005) Study of survival of motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) gene deletions in SMA patients. J Neurol 252(6):667\u2013671","journal-title":"J Neurol"},{"issue":"1","key":"8399_CR100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.braindev.2008.08.012","volume":"31","author":"MS Watihayati","year":"2009","unstructured":"Watihayati MS et al (2009) Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy. Brain Dev 31(1):42\u201345","journal-title":"Brain Dev"},{"issue":"6","key":"8399_CR101","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1523\/JNEUROSCI.22-06-02035.2002","volume":"22","author":"JK Maier","year":"2002","unstructured":"Maier JK et al (2002) The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 22(6):2035\u20132043","journal-title":"J Neurosci"},{"issue":"12","key":"8399_CR102","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1089\/08977150152725632","volume":"18","author":"JS Hutchison","year":"2001","unstructured":"Hutchison JS et al (2001) Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. J Neurotrauma 18(12):1333\u20131347","journal-title":"J Neurotrauma"},{"issue":"6563","key":"8399_CR103","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/379349a0","volume":"379","author":"P Liston","year":"1996","unstructured":"Liston P et al (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379(6563):349\u2013353","journal-title":"Nature"},{"issue":"6","key":"8399_CR104","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1046\/j.1460-9568.2000.00098.x","volume":"12","author":"D Perrelet","year":"2000","unstructured":"Perrelet D et al (2000) IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12(6):2059\u20132067","journal-title":"Eur J Neurosci"},{"issue":"5","key":"8399_CR105","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1073\/pnas.040469797","volume":"97","author":"M Holcik","year":"2000","unstructured":"Holcik M et al (2000) The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury. Proc Natl Acad Sci USA 97(5):2286\u20132290","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"8399_CR106","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/hmg\/9.17.2479","volume":"9","author":"R Gotz","year":"2000","unstructured":"Gotz R et al (2000) The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum Mol Genet 9(17):2479\u20132489","journal-title":"Hum Mol Genet"},{"issue":"12","key":"8399_CR107","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","volume":"114","author":"M Azzouz","year":"2004","unstructured":"Azzouz M et al (2004) Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest 114(12):1726\u20131731","journal-title":"J Clin Invest"},{"issue":"3","key":"8399_CR108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28(3):271\u2013274","journal-title":"Nat Biotechnol"},{"issue":"Suppl 1","key":"8399_CR109","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0169-5002(03)00147-8","volume":"41","author":"RA Stahel","year":"2003","unstructured":"Stahel RA, Zangemeister-Wittke U (2003) Antisense oligonucleotides for cancer therapy\u2014an overview. Lung Cancer 41(Suppl 1):S81\u2013S88","journal-title":"Lung Cancer"},{"issue":"26","key":"8399_CR110","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","volume":"357","author":"JC Deutekom van","year":"2007","unstructured":"van Deutekom JC et al (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357(26):2677\u20132686","journal-title":"N Engl J Med"},{"issue":"9791","key":"8399_CR111","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","volume":"378","author":"S Cirak","year":"2011","unstructured":"Cirak S et al (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378(9791):595\u2013605","journal-title":"Lancet"},{"issue":"4","key":"8399_CR112","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua Y et al (2007) Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 5(4):e73","journal-title":"PLoS Biol"},{"issue":"72","key":"8399_CR113","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini MA et al (2011) Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 3(72):72ra18","journal-title":"Sci Transl Med"},{"issue":"1","key":"8399_CR114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2009.10.002","volume":"61","author":"ST Lim","year":"2010","unstructured":"Lim ST, Airavaara M, Harvey BK (2010) Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 61(1):14\u201326","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"8399_CR115","first-page":"29","volume":"51","author":"Y Ruixing","year":"2004","unstructured":"Ruixing Y, Dezhai Y, Jiaquan L (2004) Effects of cardiotrophin-1 on hemodynamics and cardiomyocyte apoptosis in rats with acute myocardial infarction. J Med Invest 51(1\u20132):29\u201337","journal-title":"J Med Invest"},{"issue":"1","key":"8399_CR116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2005.07.018","volume":"387","author":"TC Wen","year":"2005","unstructured":"Wen TC et al (2005) Cardiotrophin-1 protects cortical neuronal cells against free radical-induced injuries in vitro. Neurosci Lett 387(1):38\u201342","journal-title":"Neurosci Lett"},{"issue":"18","key":"8399_CR117","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/hmg\/10.18.1925","volume":"10","author":"T Bordet","year":"2001","unstructured":"Bordet T et al (2001) Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet 10(18):1925\u20131933","journal-title":"Hum Mol Genet"},{"issue":"11","key":"8399_CR118","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","volume":"12","author":"JC Lesbordes","year":"2003","unstructured":"Lesbordes JC et al (2003) Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. Hum Mol Genet 12(11):1233\u20131239","journal-title":"Hum Mol Genet"},{"issue":"5","key":"8399_CR119","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/jnr.22269","volume":"88","author":"H Peng","year":"2010","unstructured":"Peng H et al (2010) Caspase inhibition by cardiotrophin-1 prevents neuronal death in vivo and in vitro. J Neurosci Res 88(5):1041\u20131051","journal-title":"J Neurosci Res"},{"issue":"11","key":"8399_CR120","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn1789","volume":"9","author":"PH Ozdinler","year":"2006","unstructured":"Ozdinler PH, Macklis JD (2006) IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 9(11):1371\u20131381","journal-title":"Nat Neurosci"},{"issue":"3","key":"8399_CR121","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I et al (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63(3):316\u2013328","journal-title":"Neuron"},{"issue":"5634","key":"8399_CR122","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK et al (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301(5634):839\u2013842","journal-title":"Science"},{"issue":"9","key":"8399_CR123","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","volume":"20","author":"M Bosch-Marce","year":"2011","unstructured":"Bosch-Marce M et al (2011) Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet 20(9):1844\u20131853","journal-title":"Hum Mol Genet"},{"issue":"4","key":"8399_CR124","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini MA et al (2010) CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J Clin Invest 120(4):1253\u20131264","journal-title":"J Clin Invest"},{"issue":"4","key":"8399_CR125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","volume":"20","author":"E Dominguez","year":"2011","unstructured":"Dominguez E et al (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20(4):681\u2013693","journal-title":"Hum Mol Genet"},{"issue":"7","key":"8399_CR126","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky PN et al (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 21(7):1625\u20131638","journal-title":"Hum Mol Genet"},{"issue":"1","key":"8399_CR127","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","volume":"45","author":"LK Tsai","year":"2012","unstructured":"Tsai LK et al (2012) IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice. Neurobiol Dis 45(1):272\u2013279","journal-title":"Neurobiol Dis"},{"issue":"2","key":"8399_CR128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/hum.2010.114","volume":"22","author":"M Shababi","year":"2011","unstructured":"Shababi M, Glascock J, Lorson CL (2011) Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy. Hum Gene Ther 22(2):135\u2013144","journal-title":"Hum Gene Ther"},{"issue":"3","key":"8399_CR129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-007-0327-1","volume":"115","author":"G Simic","year":"2008","unstructured":"Simic G et al (2008) Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy. Acta Neuropathol 115(3):313\u2013326","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8399_CR130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nbd.2011.02.003","volume":"42","author":"A Garcera","year":"2011","unstructured":"Garcera A et al (2011) A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons. Neurobiol Dis 42(3):415\u2013426","journal-title":"Neurobiol Dis"},{"issue":"8","key":"8399_CR131","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI46276","volume":"121","author":"F Farooq","year":"2011","unstructured":"Farooq F et al (2011) Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway. J Clin Invest 121(8):3042\u20133050","journal-title":"J Clin Invest"},{"issue":"8","key":"8399_CR132","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nchembio.595","volume":"7","author":"NR Makhortova","year":"2011","unstructured":"Makhortova NR et al (2011) A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol 7(8):544\u2013552","journal-title":"Nat Chem Biol"},{"issue":"5","key":"8399_CR133","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/ddl482","volume":"16","author":"CH Ting","year":"2007","unstructured":"Ting CH et al (2007) Stat5 constitutive activation rescues defects in spinal muscular atrophy. Hum Mol Genet 16(5):499\u2013514","journal-title":"Hum Mol Genet"},{"issue":"19","key":"8399_CR134","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML et al (2000) Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97(19):10526\u201310531","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"8399_CR135","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1161\/STROKEAHA.109.555789","volume":"40","author":"J Minnerup","year":"2009","unstructured":"Minnerup J et al (2009) The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke 40(9):3113\u20133120","journal-title":"Stroke"},{"key":"8399_CR136","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2009.08.025","volume":"1296","author":"A Kondo","year":"2009","unstructured":"Kondo A et al (2009) Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats. Brain Res 1296:127\u2013136","journal-title":"Brain Res"},{"issue":"5681","key":"8399_CR137","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M et al (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305(5681):239\u2013242","journal-title":"Science"},{"issue":"1","key":"8399_CR138","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.expneurol.2006.11.002","volume":"204","author":"JF Grunfeld","year":"2007","unstructured":"Grunfeld JF et al (2007) Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model. Exp Neurol 204(1):260\u2013263","journal-title":"Exp Neurol"},{"issue":"5391","key":"8399_CR139","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145\u20131147","journal-title":"Science"},{"issue":"Pt 2","key":"8399_CR140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awp318","volume":"133","author":"S Corti","year":"2010","unstructured":"Corti S et al (2010) Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice. Brain 133(Pt 2):465\u2013481","journal-title":"Brain"},{"issue":"7227","key":"8399_CR141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD et al (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227):277\u2013280","journal-title":"Nature"},{"issue":"17","key":"8399_CR142","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG et al (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98(17):9808\u20139813","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"8399_CR143","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L et al (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12(19):2481\u20132489","journal-title":"Hum Mol Genet"},{"issue":"1","key":"8399_CR144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C et al (2004) Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 12(1):59\u201365","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"8399_CR145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ et al (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54(5):647\u2013654","journal-title":"Ann Neurol"},{"issue":"4","key":"8399_CR146","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","volume":"64","author":"HL Narver","year":"2008","unstructured":"Narver HL et al (2008) Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann Neurol 64(4):465\u2013470","journal-title":"Ann Neurol"},{"issue":"1","key":"8399_CR147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0925-4439(01)00029-1","volume":"1536","author":"AJ Grierson","year":"2001","unstructured":"Grierson AJ, Shaw CE, Miller CC (2001) Androgen induced cell death in SHSY5Y neuroblastoma cells expressing wild-type and spinal bulbar muscular atrophy mutant androgen receptors. Biochim Biophys Acta 1536(1):13\u201320","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8399_CR148","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","volume":"68","author":"E Mercuri","year":"2007","unstructured":"Mercuri E et al (2007) Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 68(1):51\u201355","journal-title":"Neurology"},{"issue":"8","key":"8399_CR149","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","volume":"5","author":"KJ Swoboda","year":"2010","unstructured":"Swoboda KJ et al (2010) SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS One 5(8):e12140","journal-title":"PLoS One"},{"issue":"7","key":"8399_CR150","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","volume":"6","author":"JT Kissel","year":"2011","unstructured":"Kissel JT et al (2011) SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLoS One 6(7):e21296","journal-title":"PLoS One"},{"issue":"2","key":"8399_CR151","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.20548","volume":"58","author":"SM Grzeschik","year":"2005","unstructured":"Grzeschik SM et al (2005) Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol 58(2):194\u2013202","journal-title":"Ann Neurol"},{"issue":"24","key":"8399_CR152","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","volume":"75","author":"TH Chen","year":"2010","unstructured":"Chen TH et al (2010) Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy. Neurology 75(24):2190\u20132197","journal-title":"Neurology"},{"issue":"11","key":"8399_CR153","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"AK Bevan","year":"2011","unstructured":"Bevan AK et al (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther 19(11):1971\u20131980","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"8399_CR154","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","volume":"191","author":"RG Miller","year":"2001","unstructured":"Miller RG et al (2001) A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci 191(1\u20132):127\u2013131","journal-title":"J Neurol Sci"},{"key":"8399_CR155","doi-asserted-by":"crossref","unstructured":"ALS CNTF Treatment Study Group (1996) A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 46:1244\u20131249","DOI":"10.1212\/WNL.46.5.1244"},{"key":"8399_CR156","unstructured":"Kasarkis E (1999) A controlled trial of recombinant methionyl human BDNF in 1097 ALS: the BDNF Study Group (Phase III). Neurology 52(7):1427\u201333"},{"issue":"2","key":"8399_CR157","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/14660820510028412","volume":"6","author":"M Beck","year":"2005","unstructured":"Beck M et al (2005) Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 6(2):100\u2013103","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"22","key":"8399_CR158","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","volume":"71","author":"EJ Sorenson","year":"2008","unstructured":"Sorenson EJ et al (2008) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71(22):1770\u20131775","journal-title":"Neurology"},{"issue":"6","key":"8399_CR159","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/me.8.6.674","volume":"8","author":"CV Clevenger","year":"1994","unstructured":"Clevenger CV, Medaglia MV (1994) The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol Endocrinol 8(6):674\u2013681","journal-title":"Mol Endocrinol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8399-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T16:38:05Z","timestamp":1714840685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,13]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["8399"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8399-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,13]]}}}